Close Menu

NEW YORK — Enable Biosciences said on Tuesday that it has been awarded a $1.5 million grant from the National Institute for Diabetes and Digestive and Kidney Diseases (NIDDK) to continue work on a dried blood spot-based immunoassay for type 1 diabetes.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.